Countries citing papers authored by Marek Spaczyński
Since
Specialization
Citations
This map shows the geographic impact of Marek Spaczyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Spaczyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Spaczyński more than expected).
Fields of papers citing papers by Marek Spaczyński
This network shows the impact of papers produced by Marek Spaczyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Spaczyński. The network helps show where Marek Spaczyński may publish in the future.
Co-authorship network of co-authors of Marek Spaczyński
This figure shows the co-authorship network connecting the top 25 collaborators of Marek Spaczyński.
A scholar is included among the top collaborators of Marek Spaczyński based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Marek Spaczyński. Marek Spaczyński is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Seme, Katja, Polona J. Maver, Ірина Филиппова, et al.. (2013). Current status of human papillomavirus vaccination implementation in central and eastern Europe.. PubMed. 22(1). 21–5.17 indexed citations
4.
Drews, Krzysztof, Agata Karowicz-Bilińska, Przemysław Oszukowski, et al.. (2011). [Expert review of Polish Gynecological Society regarding micronutrient supplementation in pregnancy].. PubMed. 82(7). 550–3.8 indexed citations
5.
Bednarek, Wiesława, Agata Karowicz-Bilińska, Jan Kotarski, et al.. (2011). [Position of Experts Panel of the Polish Gynecological Society in the application of low molecular weight heparin - nadroparin calcium (Fraxiparine) in obstetrics and gynecology].. PubMed. 82(3). 230–3.1 indexed citations
Spaczyński, Marek, et al.. (2010). [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].. PubMed. 81(9). 655–63.13 indexed citations
8.
Surowiak, Paweł, Ewa Nowak‐Markwitz, Marcin Michalak, et al.. (2008). Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.. PubMed. 79(12). 826–34.5 indexed citations
9.
Bidziński, Mariusz, Romuald Dębski, Witold Kędzia, et al.. (2008). [Statement of the Expert Group of Polish Gynecologic Society on the cervical adenocarcinoma prophylaxis].. PubMed. 79(10). 710–4.2 indexed citations
Spaczyński, Marek. (2005). Rekomendacje Polskiego Towarzystwa Ginekologicznego w sprawie diagnostyki i leczenia nietrzymania moczu u kobiet. 13(5). 45–53.6 indexed citations
14.
Spaczyński, Marek. (2005). Rekomendacje Zarządu Głównego PTG w sprawie profilaktyki i wczesnej diagnostyki zmian w gruczole sutkowym (23.3.2005 r.). 4(2). 8–9.2 indexed citations
15.
Spaczyński, Marek. (2004). Rekomendacje Polskiego Towarzystwa Ginekologicznego w zakresie zakażeń przenoszonych drogą płciową w położnictwie i ginekologii. 3(4). 15–21.
16.
Spaczyński, Marek. (2004). Diagnostyka, profilaktyka i wczesne wykrywanie raka szyjki macicy – rekomendacje Polskiego Towarzystwa Ginekologicznego. 12(3). 6–8.1 indexed citations
17.
Spaczyński, Marek. (2004). Wprowadzenie do Rekomendacji Zarządu Głównego PTG w sprawie stosowania hormonalnej terapii zastępczej (Stan wiedzy na dzień 10.07.2004 r. – prof. dr hab. n. med. Tomasz Pertyński). 12(4). 2–4.
18.
Nowak‐Markwitz, Ewa, Marcin Michalak, & Marek Spaczyński. (2003). Prediction value of serum Ca 125 level in benefit secondary cytoreduction in advanced ovarian cancer patients. Contemporary Oncology/Współczesna Onkologia. 7(9). 662–667.2 indexed citations
19.
Kędzia, Witold, et al.. (2002). Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers.. PubMed. 40(1). 37–41.19 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.